In liver fibrosis induced by CCL4, miR-27b-3p targets the Yes-associated protein (YAP)/Lysyloxidase-like2 (LOXL2) pathway, effectively slowing down the progression of fibrosis [56]. Here, CCL4 is linked to Hepatic fibrosis.